April 21 (Reuters) - Avalo Therapeutics Inc AVTX.O :
* AVALO THERAPEUTICS INC - ON APRIL 20 DELIVERED WRITTEN
NOTICE TO
CANTOR FITZGERALD & CO. & RBC CAPITAL MARKETS, LLC TO TERMINATE
SALES AGREEMENT
* AVALO THERAPEUTICS INC - DELIVERED WRITTEN NOTICE TO
CANTOR &
RBC TO TERMINATE SALES AGREEMENT, EFFECTIVE NO LATER THAN APRIL
30, 2023
* AVALO THERAPEUTICS INC - IS NOT SUBJECT TO ANY
TERMINATION
PENALTIES RELATED TO TERMINATION OF THE SALES AGREEMENT
Further company coverage: AVTX.O
((Reuters.Briefs@thomsonreuters.com;))